13F
中

ATNM ACTINIUM PHARMACEUTICALS INC

2026Q1 · CUSIP 00507W206 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
53
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
28
Δ whales
-6
Inst. holding value
$5M
New positions
7
Closed positions
14
Price momentum (1Q)
—
Put / Call
0/2

Breadth history (34 quarters)

2020Q2: Δ+0 · h=1 2020Q3: Δ+40 · h=41 2020Q4: Δ+7 · h=48 2021Q1: Δ-8 · h=40 2021Q2: Δ-1 · h=39 2021Q3: Δ+5 · h=44 2021Q4: Δ-1 · h=43 2022Q1: Δ-5 · h=38 2022Q2: Δ+13 · h=51 2022Q3: Δ+6 · h=57 2022Q4: Δ+3 · h=60 2023Q1: Δ+6 · h=66 2023Q2: Δ+6 · h=72 2023Q3: Δ-13 · h=59 2023Q4: Δ+1 · h=60 2024Q1: Δ+8 · h=68 2024Q2: Δ+7 · h=75 2024Q3: Δ-2 · h=73 2024Q4: Δ-3 · h=70 2025Q1: Δ+1 · h=71 2025Q2: Δ-6 · h=65 2025Q3: Δ-4 · h=61 2025Q4: Δ-1 · h=60 2026Q1: Δ-7 · h=53 2020Q2: holders=1 2020Q3: holders=41 2020Q4: holders=48 2021Q1: holders=40 2021Q2: holders=39 2021Q3: holders=44 2021Q4: holders=43 2022Q1: holders=38 2022Q2: holders=51 2022Q3: holders=57 2022Q4: holders=60 2023Q1: holders=66 2023Q2: holders=72 2023Q3: holders=59 2023Q4: holders=60 2024Q1: holders=68 2024Q2: holders=75 2024Q3: holders=73 2024Q4: holders=70 2025Q1: holders=71 2025Q2: holders=65 2025Q3: holders=61 2025Q4: holders=60 2026Q1: holders=53 -40 -20 +0 +20 +40 04079 20Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q2 Top 10% — —
2020Q3 Top 4% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
2
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.76
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.33 2022-09-30: EPS -0.38 2022-12-31: EPS -0.43 2023-03-31: EPS -0.43 2023-06-30: EPS -0.58 2023-09-30: EPS -0.49 2023-12-31: EPS -0.33 2024-03-31: EPS -0.31 2024-06-30: EPS -0.38 2024-09-30: EPS -0.37 2024-12-31: EPS -0.21 2025-03-31: EPS -0.51 2025-06-30: EPS -0.22 2025-09-30: EPS -0.16 2025-12-31: EPS -0.20 2026-03-31: EPS -0.18 -0.64 -0.32 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)